Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Calcitonin"" wg kryterium: Temat


Tytuł :
[Effects of manual loading on calcitonin gene-related peptide and nerve growth factor in rats with chronic low back pain].
Autorzy :
Lyu ZZ; Yueyang Hospital of Integrated Trditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Zhu QG; Yueyang Hospital of Integrated Trditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Kong LJ; Yueyang Hospital of Integrated Trditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Cheng YB; Yueyang Hospital of Integrated Trditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Guo GX; Yueyang Hospital of Integrated Trditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Zhou X; Yueyang Hospital of Integrated Trditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Zhang SP; Yueyang Hospital of Integrated Trditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Fang M; Yueyang Hospital of Integrated Trditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
Pokaż więcej
Źródło :
Zhongguo gu shang = China journal of orthopaedics and traumatology [Zhongguo Gu Shang] 2021 Mar 25; Vol. 34 (3), pp. 282-7.
Typ publikacji :
Journal Article
MeSH Terms :
Calcitonin Gene-Related Peptide*
Low Back Pain*/therapy
Animals ; Calcitonin ; Male ; Nerve Growth Factor/genetics ; Rats ; Rats, Sprague-Dawley
Czasopismo naukowe
Tytuł :
[Gepants and Ditans].
Autorzy :
Kowa H; Department of Neurology, National Hospital Organization Matsue Medical Center.
Pokaż więcej
Źródło :
Brain and nerve = Shinkei kenkyu no shinpo [Brain Nerve] 2021 Apr; Vol. 73 (4), pp. 315-325.
Typ publikacji :
Journal Article
MeSH Terms :
Calcitonin Gene-Related Peptide Receptor Antagonists*
Migraine Disorders*/drug therapy
Calcitonin Gene-Related Peptide ; Humans ; Japan ; Tryptamines/therapeutic use
Czasopismo naukowe
Tytuł :
[Migraine Mechanisms: In Relation to the Premonitory Phase and CGRP/CGRP Receptor Antagonists].
Autorzy :
Awaki E; Department of Neurology, Saiseikai Sakaiminato General Hospital.
Takeshima T
Pokaż więcej
Źródło :
Brain and nerve = Shinkei kenkyu no shinpo [Brain Nerve] 2021 Apr; Vol. 73 (4), pp. 303-313.
Typ publikacji :
Journal Article
MeSH Terms :
Calcitonin Gene-Related Peptide*/metabolism
Migraine Disorders*/drug therapy
Brain/metabolism ; Calcitonin Gene-Related Peptide Receptor Antagonists ; Humans ; Neurons/metabolism
Czasopismo naukowe
Tytuł :
[Application of CGRP-Related Monoclonal Antibodies in Migraine Management].
Autorzy :
Shibata M; Department of Neurology, Tokyo Dental College Ichikawa General Hospital.
Pokaż więcej
Źródło :
Brain and nerve = Shinkei kenkyu no shinpo [Brain Nerve] 2021 Apr; Vol. 73 (4), pp. 327-337.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Calcitonin Gene-Related Peptide*
Migraine Disorders*/drug therapy
Animals ; Antibodies, Monoclonal/therapeutic use ; Calcitonin ; Trigeminal Ganglion
Czasopismo naukowe
Tytuł :
[Migraine prophylaxis-all just antibodies? : Medical and nonmedical migraine preventive treatment in times of CGRP antibodies].
Autorzy :
Hamann T; Klinik und Poliklinik für Neurologie, Kopfschmerzzentrum Nord-Ost, Universitätsmedizin Rostock, Gehlsheimer Straße 20, 18147, Rostock, Deutschland. .
Kamm K; Neurologische Klinik und Poliklinik, Oberbayrisches Kopfschmerzzentrum, Klinikum der Universität München, Ludwig-Maximilians-Universität München, München, Deutschland.
Kropp P; Institut für Medizinische Psychologie und Medizinische Soziologie, Kopfschmerzzentrum Nord-Ost, Universitätsmedizin Rostock, Rostock, Deutschland.
Rimmele F; Klinik und Poliklinik für Neurologie, Kopfschmerzzentrum Nord-Ost, Universitätsmedizin Rostock, Gehlsheimer Straße 20, 18147, Rostock, Deutschland.
Jürgens TP; Klinik und Poliklinik für Neurologie, Kopfschmerzzentrum Nord-Ost, Universitätsmedizin Rostock, Gehlsheimer Straße 20, 18147, Rostock, Deutschland.
Pokaż więcej
Transliterated Title :
Migräneprophylaxe – alles nur noch Antikörper? : Medikamentöse und nicht-medikamentöse Migräneprophylaxe in Zeiten der CGRP-Antikörper.
Źródło :
Schmerz (Berlin, Germany) [Schmerz] 2020 Dec; Vol. 34 (6), pp. 476-485. Date of Electronic Publication: 2020 Sep 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antibodies, Monoclonal*/therapeutic use
Calcitonin Gene-Related Peptide*
Migraine Disorders*/prevention & control
Calcitonin Gene-Related Peptide Receptor Antagonists ; Humans ; Receptors, Calcitonin Gene-Related Peptide
Czasopismo naukowe
Tytuł :
Immunogenicity of biologic therapies for migraine: a review of current evidence.
Autorzy :
Cohen JM; Teva Pharmaceuticals, West Chester, PA, USA. .
Ning X; Teva Pharmaceuticals, West Chester, PA, USA.
Kessler Y; Teva Pharmaceuticals, West Chester, PA, USA.
Rasamoelisolo M; Teva Pharmaceuticals, West Chester, PA, USA.
Campos VR; Teva Pharmaceuticals, West Chester, PA, USA.
Seminerio MJ; Teva Pharmaceuticals, West Chester, PA, USA.
Krasenbaum LJ; Teva Pharmaceuticals, West Chester, PA, USA.
Shen H; Teva Pharmaceuticals, West Chester, PA, USA.
Stratton J; Teva Pharmaceuticals, West Chester, PA, USA.
Pokaż więcej
Źródło :
The journal of headache and pain [J Headache Pain] 2021 Jan 07; Vol. 22 (1), pp. 3. Date of Electronic Publication: 2021 Jan 07.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Calcitonin Gene-Related Peptide Receptor Antagonists*
Migraine Disorders*
Biological Therapy ; Calcitonin Gene-Related Peptide ; Humans
Czasopismo naukowe
Tytuł :
Changing levels of sex hormones and calcitonin gene-related peptide (CGRP) during a woman's life: Implications for the efficacy and safety of novel antimigraine medications.
Autorzy :
de Vries Lentsch S; Department of Neurology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, the Netherlands; Div. of Pharmacology, Dept. of Internal Medicine, Erasmus University Medical Centre, PO Box 2040, 3000 CA Rotterdam, the Netherlands.
Rubio-Beltrán E; Div. of Pharmacology, Dept. of Internal Medicine, Erasmus University Medical Centre, PO Box 2040, 3000 CA Rotterdam, the Netherlands.
MaassenVanDenBrink A; Div. of Pharmacology, Dept. of Internal Medicine, Erasmus University Medical Centre, PO Box 2040, 3000 CA Rotterdam, the Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Maturitas [Maturitas] 2021 Mar; Vol. 145, pp. 73-77. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Calcitonin Gene-Related Peptide/*antagonists & inhibitors
Migraine Disorders/*drug therapy
Analgesics/therapeutic use ; Animals ; Antibodies, Monoclonal/therapeutic use ; Calcitonin Gene-Related Peptide/blood ; Calcitonin Gene-Related Peptide/immunology ; Calcitonin Gene-Related Peptide Receptor Antagonists/therapeutic use ; Female ; Gonadal Steroid Hormones/blood ; Humans ; Migraine Disorders/blood ; Sex Characteristics ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB.
Autorzy :
Tringali G; Department of Healthcare Surveillance and Bioethics, Section of Pharmacology, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy.
Vollono C; Neurofisiopatologia - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Neurologia - Università Cattolica del Sacro Cuore, Rome, Italy.
Calabresi P; Neurologia - Università Cattolica del Sacro Cuore, Rome, Italy.; Neurologia - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Navarra P; Department of Healthcare Surveillance and Bioethics, Section of Pharmacology, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168, Rome, Italy. .; Pharmacology - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy. .
Pokaż więcej
Źródło :
The journal of headache and pain [J Headache Pain] 2020 Oct 21; Vol. 21 (1), pp. 124. Date of Electronic Publication: 2020 Oct 21.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized*
Calcitonin Gene-Related Peptide*
Humans ; Plasma ; Receptors, Calcitonin Gene-Related Peptide
Czasopismo naukowe
Tytuł :
Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension.
Autorzy :
Yiangou A; Metabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TH, UK.; Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Mitchell JL; Metabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TH, UK.; Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Vijay V; Metabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TH, UK.; Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Grech O; Metabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TH, UK.; Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Bilton E; Birmingham Neuro-Ophthalmology, Ophthalmology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Lavery GG; Metabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TH, UK.; Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Fisher C; Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Edwards J; Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Mollan SP; Birmingham Neuro-Ophthalmology, Ophthalmology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK.
Sinclair AJ; Metabolic Neurology, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK. .; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TH, UK. .; Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK. .
Pokaż więcej
Źródło :
The journal of headache and pain [J Headache Pain] 2020 Sep 25; Vol. 21 (1), pp. 116. Date of Electronic Publication: 2020 Sep 25.
Typ publikacji :
Journal Article
MeSH Terms :
Calcitonin Gene-Related Peptide*
Pseudotumor Cerebri*/complications
Pseudotumor Cerebri*/drug therapy
Antibodies, Monoclonal ; Calcitonin ; Headache ; Humans ; Quality of Life
Czasopismo naukowe
Tytuł :
Targeting CGRP in migraine: a matter of choice and dose.
Autorzy :
Al-Hassany L; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.
Van Den Brink AM; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Neurology [Lancet Neurol] 2020 Sep; Vol. 19 (9), pp. 712-713.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Calcitonin Gene-Related Peptide*
Migraine Disorders*
Calcitonin Gene-Related Peptide Receptor Antagonists ; Double-Blind Method ; Humans
Czasopismo naukowe
Tytuł :
CGRP Receptor Antagonism in COVID-19: Potential Cardiopulmonary Adverse Effects.
Autorzy :
Skaria T; Institute of Veterinary Physiology and Zürich Center for Integrative Human Physiology, University of Zürich, Zürich, Switzerland.
Wälchli T; Department of Fundamental Neurobiology, Krembil Research Institute, University Health Network, University of Toronto, Toronto, Canada; Division of Neurosurgery, Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Canada; Group of Brain Vasculature and Neurovascular Unit, Division of Neurosurgery, Department of Clinical Neurosciences, University Hospital Geneva, Geneva, Switzerland; Group of CNS Angiogenesis and Neurovascular Link, Institute for Regenerative Medicine, Neuroscience Center Zürich, University Hospital Zürich, Zürich, Switzerland; Division of Neurosurgery, University Hospital Zürich, Zürich, Switzerland.
Vogel J; Institute of Veterinary Physiology and Zürich Center for Integrative Human Physiology, University of Zürich, Zürich, Switzerland. Electronic address: .
Pokaż więcej
Źródło :
Trends in molecular medicine [Trends Mol Med] 2021 Jan; Vol. 27 (1), pp. 7-10. Date of Electronic Publication: 2020 Oct 22.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*/drug therapy
COVID-19*/metabolism
COVID-19*/pathology
Calcitonin Gene-Related Peptide Receptor Antagonists*/adverse effects
Calcitonin Gene-Related Peptide Receptor Antagonists*/therapeutic use
Heart Diseases*/chemically induced
Heart Diseases*/metabolism
Heart Diseases*/pathology
Receptors, Calcitonin Gene-Related Peptide/*metabolism
SARS-CoV-2/*metabolism
Animals ; Humans
Czasopismo naukowe
Tytuł :
Effects of Calcitonin Gene-related Peptide on Dental Pulp Stem Cell Viability, Proliferation, and Differentiation.
Autorzy :
Michot B; Department of Restorative Dentistry and Biomaterials Sciences, Harvard School of Dental Medicine, Boston, Massachusetts; Department of Endodontics, New York University College of Dentistry, New York, New York. Electronic address: .
Casey SM; Department of Restorative Dentistry and Biomaterials Sciences, Harvard School of Dental Medicine, Boston, Massachusetts; Department of Endodontics, New York University College of Dentistry, New York, New York.
Gibbs JL; Department of Restorative Dentistry and Biomaterials Sciences, Harvard School of Dental Medicine, Boston, Massachusetts; Department of Endodontics, New York University College of Dentistry, New York, New York.
Pokaż więcej
Źródło :
Journal of endodontics [J Endod] 2020 Jul; Vol. 46 (7), pp. 950-956. Date of Electronic Publication: 2020 May 06.
Typ publikacji :
Journal Article
MeSH Terms :
Calcitonin Gene-Related Peptide*
Dental Pulp*
Calcitonin ; Cell Differentiation ; Cell Proliferation ; Cell Survival ; Cells, Cultured ; Stem Cells
Czasopismo naukowe
Tytuł :
Palmatine alleviates hyperalgesia by inhibiting the expression of calcitonin gene-related peptide in the trigeminal ganglion of rats with chronic constriction injury of the infraorbital nerve.
Autorzy :
He L; Affiliated Stomatological Hospital of Nanchang University, Nanchang, Jiangxi, China.
Liu L; Affiliated Stomatological Hospital of Nanchang University, Nanchang, Jiangxi, China.
Guan S; Department of Physiology, Basic Medical College, Nanchang University, Nanchang, Jiangxi, China.
Zheng X; Queen Mary college of grade 2015, Nanchang University, Nanchang, Jiangxi, China.
Ge H; Department of Physiology, Basic Medical College, Nanchang University, Nanchang, Jiangxi, China.
Yin C; Affiliated Stomatological Hospital of Nanchang University, Nanchang, Jiangxi, China.
Shen Y; Department of Physiology, Basic Medical College, Nanchang University, Nanchang, Jiangxi, China.
Tan M; Department of Physiology, Basic Medical College, Nanchang University, Nanchang, Jiangxi, China.
Wang C; Second Clinic Medical College of Grade 2017, Nanchang University, Nanchang, Jiangxi, China.
Gao Y; Department of Physiology, Basic Medical College, Nanchang University, Nanchang, Jiangxi, China; Jiangxi Provincial Key Laboratory of Autonomic Nervous Function and Disease, Nanchang, Jiangxi, China.
Xiong W; Affiliated Stomatological Hospital of Nanchang University, Nanchang, Jiangxi, China; Jiangxi Provincial Key Laboratory of Oral Biomedicine, Nanchang, Jiangxi, China. Electronic address: .
Pokaż więcej
Źródło :
The British journal of oral & maxillofacial surgery [Br J Oral Maxillofac Surg] 2020 May; Vol. 58 (4), pp. 443-450. Date of Electronic Publication: 2020 Mar 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Calcitonin Gene-Related Peptide*
Trigeminal Ganglion*
Animals ; Berberine Alkaloids ; Calcitonin ; Constriction ; Humans ; Hyperalgesia ; Male ; Quality of Life ; Rats ; Rats, Sprague-Dawley
Czasopismo naukowe
Tytuł :
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells.
Autorzy :
Larrue C; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.; Geneva University Hospitals, University of Geneva, Geneva, Switzerland.
Guiraud N; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Mouchel PL; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.; Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, F-31100, Toulouse, France.
Dubois M; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Farge T; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Gotanègre M; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Bosc C; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Saland E; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Nicolau-Travers ML; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.; Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, F-31100, Toulouse, France.
Sabatier M; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Serhan N; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Sahal A; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Boet E; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Mouche S; Geneva University Hospitals, University of Geneva, Geneva, Switzerland.
Heydt Q; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Aroua N; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Stuani L; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.
Kaoma T; Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, L-1445, Strassen, Luxembourg.
Angenendt L; Department of Medicine A, University Hospital Münster, Münster, Germany.
Mikesch JH; Department of Medicine A, University Hospital Münster, Münster, Germany.
Schliemann C; Department of Medicine A, University Hospital Münster, Münster, Germany.
Vergez F; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.; Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, F-31100, Toulouse, France.
Tamburini J; Geneva University Hospitals, University of Geneva, Geneva, Switzerland.; Institut Cochin, Département Développement, Reproduction et Cancer, CNRS UMR8104, Inserm U1016, Paris, France.; Université Paris Descartes, Faculté de Médecine Sorbonne Paris Cité, Paris, France.
Récher C; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France.; Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, CHU de Toulouse, F-31100, Toulouse, France.
Sarry JE; Centre de Recherches en Cancérologie de Toulouse, UMR1037, Inserm, Université de Toulouse 3 Paul Sabatier, Equipe Labellisée LIGUE 2018, F-31037, Toulouse, France. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Jan 18; Vol. 12 (1), pp. 422. Date of Electronic Publication: 2021 Jan 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adrenomedullin/*metabolism
Antineoplastic Agents/*pharmacology
Calcitonin Receptor-Like Protein/*metabolism
Drug Resistance, Neoplasm/*genetics
Leukemia, Myeloid, Acute/*drug therapy
Neoplasm Recurrence, Local/*genetics
Animals ; Antineoplastic Agents/therapeutic use ; Calcitonin Gene-Related Peptide/metabolism ; Calcitonin Receptor-Like Protein/genetics ; Cell Cycle/drug effects ; Cell Cycle/genetics ; Cell Line, Tumor ; DNA Repair/drug effects ; DNA Repair/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Gene Knockdown Techniques ; Humans ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/mortality ; Leukemia, Myeloid, Acute/pathology ; Male ; Mice ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/prevention & control ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/pathology ; Oxidative Phosphorylation/drug effects ; Primary Cell Culture ; Prognosis ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Central effects of erenumab in migraine patients: An event-related functional imaging study.
Autorzy :
Ziegeler C; From the Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Mehnert J; From the Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Asmussen K; From the Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
May A; From the Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. .
Pokaż więcej
Źródło :
Neurology [Neurology] 2020 Nov 17; Vol. 95 (20), pp. e2794-e2802. Date of Electronic Publication: 2020 Sep 11.
Typ publikacji :
Clinical Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain*/diagnostic imaging
Brain*/drug effects
Brain*/physiopathology
Functional Neuroimaging*
Nerve Net*/diagnostic imaging
Nerve Net*/drug effects
Nerve Net*/physiopathology
Outcome Assessment, Health Care*
Antibodies, Monoclonal, Humanized/*pharmacology
Calcitonin Gene-Related Peptide Receptor Antagonists/*pharmacology
Migraine Disorders/*drug therapy
Adult ; Antibodies, Monoclonal, Humanized/administration & dosage ; Calcitonin Gene-Related Peptide Receptor Antagonists/administration & dosage ; Connectome ; Female ; Follow-Up Studies ; Humans ; Hypothalamus/diagnostic imaging ; Hypothalamus/drug effects ; Hypothalamus/physiopathology ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Migraine Disorders/diagnostic imaging ; Migraine Disorders/physiopathology ; Nociception/physiology ; Pain Measurement ; Physical Stimulation ; Receptors, Calcitonin Gene-Related Peptide/immunology ; Spin Labels ; Trigeminal Nerve/physiopathology ; Young Adult
Czasopismo naukowe
Tytuł :
Estrogen receptors α, β and GPER in the CNS and trigeminal system - molecular and functional aspects.
Autorzy :
Warfvinge K; Department of Clinical Experimental Research, Glostrup Research Institute, Rigshospitalet, Glostrup, Denmark.; Division of Experimental Vascular Research, Department of Clinical Sciences, Lund University Hospital, Lund, Sweden.
Krause DN; Division of Experimental Vascular Research, Department of Clinical Sciences, Lund University Hospital, Lund, Sweden.; Department of Pharmacology, School of Medicine, University of California at Irvine, Irvine, CA, USA.
Maddahi A; Department of Clinical Experimental Research, Glostrup Research Institute, Rigshospitalet, Glostrup, Denmark.
Edvinsson JCA; Department of Clinical Experimental Research, Glostrup Research Institute, Rigshospitalet, Glostrup, Denmark.; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Edvinsson L; Department of Clinical Experimental Research, Glostrup Research Institute, Rigshospitalet, Glostrup, Denmark. .; Division of Experimental Vascular Research, Department of Clinical Sciences, Lund University Hospital, Lund, Sweden. .; Department of Internal Medicine, Lund University Hospital, S-22185, Lund, Sweden. .
Haanes KA; Department of Clinical Experimental Research, Glostrup Research Institute, Rigshospitalet, Glostrup, Denmark.
Pokaż więcej
Źródło :
The journal of headache and pain [J Headache Pain] 2020 Nov 10; Vol. 21 (1), pp. 131. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji :
Journal Article
MeSH Terms :
Calcitonin Gene-Related Peptide/*metabolism
Central Nervous System/*metabolism
Estrogen Receptor alpha/*metabolism
Estrogen Receptor beta/*metabolism
Trigeminal Ganglion/*metabolism
Animals ; Female ; Humans ; Male ; Migraine Disorders/physiopathology ; Neurons/metabolism ; Pituitary Adenylate Cyclase-Activating Polypeptide/metabolism ; Rats ; Rats, Sprague-Dawley ; Receptors, Calcitonin Gene-Related Peptide/metabolism ; Signal Transduction
Czasopismo naukowe
Tytuł :
Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia.
Autorzy :
Moreira LM; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Takawale A; Research Centre, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
Hulsurkar M; Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX, USA.; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA.
Menassa DA; Clinical Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.; Biological Sciences, Faculty of Life and Environmental Sciences, University of Southampton, Southampton, UK.
Antanaviciute A; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Lahiri SK; Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX, USA.; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA.
Mehta N; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Evans N; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Psarros C; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Robinson P; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Sparrow AJ; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Gillis MA; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.; Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
Ashley N; Single-Cell Genomics Facility, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Naud P; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.; Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
Barallobre-Barreiro J; King's British Heart Foundation Centre, King's College London, London, UK.
Theofilatos K; King's British Heart Foundation Centre, King's College London, London, UK.
Lee A; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Norris M; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Clarke MV; Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.
Russell PK; Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.
Casadei B; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Bhattacharya S; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Zajac JD; Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.
Davey RA; Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia.
Sirois M; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.; Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
Mead A; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Simmons A; Medical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Mayr M; King's British Heart Foundation Centre, King's College London, London, UK.
Sayeed R; Cardiothoracic Surgery, Oxford Heart Centre, John Radcliffe Hospital, Oxford, UK.
Krasopoulos G; Cardiothoracic Surgery, Oxford Heart Centre, John Radcliffe Hospital, Oxford, UK.
Redwood C; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Channon KM; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK.
Tardif JC; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.; Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
Wehrens XHT; Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX, USA.; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA.; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Nattel S; Research Centre, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada.; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.; Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.; Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.; IHU LIRYC, Fondation Bordeaux Université, Bordeaux, France.
Reilly S; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, John Radcliffe Hospital, Oxford, UK. .
Pokaż więcej
Źródło :
Nature [Nature] 2020 Nov; Vol. 587 (7834), pp. 460-465. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Paracrine Communication*
Arrhythmias, Cardiac/*metabolism
Calcitonin/*metabolism
Fibrinogen/*biosynthesis
Heart Atria/*metabolism
Myocardium/*metabolism
Animals ; Arrhythmias, Cardiac/pathology ; Arrhythmias, Cardiac/physiopathology ; Atrial Fibrillation ; Collagen Type I/metabolism ; Female ; Fibroblasts/metabolism ; Fibrosis/metabolism ; Fibrosis/pathology ; Heart Atria/cytology ; Heart Atria/pathology ; Heart Atria/physiopathology ; Humans ; Male ; Mice ; Myocardium/cytology ; Myocardium/pathology ; Myocytes, Cardiac/metabolism ; Receptors, Calcitonin/metabolism
Czasopismo naukowe
Tytuł :
[Pathophysiological role of calcitonin gene-related peptide (CGRP) in migraine and cluster headache].
Autorzy :
Meßlinger K; Institut für Physiologie und Pathophysiologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstraße 17, 91054, Erlangen, Deutschland. .
Pokaż więcej
Transliterated Title :
Bedeutung des „calcitonin gene-related peptide“ (CGRP) in der Pathophysiologie von Migräne und Clusterkopfschmerz.
Źródło :
Schmerz (Berlin, Germany) [Schmerz] 2020 Apr; Vol. 34 (2), pp. 181-187.
Typ publikacji :
Journal Article
MeSH Terms :
Calcitonin Gene-Related Peptide*
Cluster Headache*
Migraine Disorders*/genetics
Calcitonin ; Humans ; Receptors, Calcitonin Gene-Related Peptide
Czasopismo naukowe
Tytuł :
[Novel migraine treatment with CGRP-related monoclonal antibodies].
Autorzy :
Shibata M; Department of Neurology, Tokyo Dental College Ichikawa General Hospital.
Pokaż więcej
Źródło :
Rinsho shinkeigaku = Clinical neurology [Rinsho Shinkeigaku] 2020 Oct 24; Vol. 60 (10), pp. 668-676. Date of Electronic Publication: 2020 Sep 05.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Molecular Targeted Therapy*
Antibodies, Monoclonal/*administration & dosage
Calcitonin Gene-Related Peptide/*immunology
Calcitonin Gene-Related Peptide Receptor Antagonists/*administration & dosage
Migraine Disorders/*drug therapy
Migraine Disorders/*genetics
Animals ; Antibodies, Monoclonal, Humanized/administration & dosage ; Drug Development ; Humans ; Mice ; Migraine Disorders/prevention & control ; Receptors, Calcitonin Gene-Related Peptide/immunology
Czasopismo naukowe
Tytuł :
CGRP inhibitors for migraine prophylaxis: a safety review.
Autorzy :
Rivera-Mancilla E; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center , Rotterdam, The Netherlands.
Villalón CM; Department of Pharmacobiology, Cinvestav-Coapa , Mexico City, Mexico.
MaassenVanDenBrink A; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center , Rotterdam, The Netherlands.
Pokaż więcej
Źródło :
Expert opinion on drug safety [Expert Opin Drug Saf] 2020 Oct; Vol. 19 (10), pp. 1237-1250. Date of Electronic Publication: 2020 Sep 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Calcitonin Gene-Related Peptide/*antagonists & inhibitors
Calcitonin Gene-Related Peptide Receptor Antagonists/*administration & dosage
Migraine Disorders/*prevention & control
Animals ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/pharmacology ; Calcitonin Gene-Related Peptide Receptor Antagonists/adverse effects ; Calcitonin Gene-Related Peptide Receptor Antagonists/pharmacology ; Humans ; Migraine Disorders/physiopathology ; Receptors, Calcitonin Gene-Related Peptide/drug effects ; Receptors, Calcitonin Gene-Related Peptide/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies